What is Polaryx Therapeutics, Inc. 's R&D?

Polaryx Therapeutics, Inc. (PLYX) reported R&D of $679K in Q1 2026.

How has Polaryx Therapeutics, Inc. 's R&D changed year-over-year?

Polaryx Therapeutics, Inc. 's R&D decreased by 85.6% year-over-year, from $4.72M to $679K.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Polaryx Therapeutics, Inc. PLYX R&D

R&D at other companies

BioMarin PharmaceuticalsBMRN

$178.8M+12.6%

Zevra Therapeutics, Inc.ZVRA

$4.39M+34.8%

Eton Pharmaceuticals, Inc.ETON

$1.88M+61.5%

XER

Xeris Biopharma Holdings, Inc.XERS

$8.78M+13.3%

Relay Therapeutics, Inc.RLAY

$70.56M-4.4%

PVL

Palvella TherapeuticsPVLA

$9.33M+129%

Segments

By segment

See full

Lysosomal Storage Disorders$679K-85.6%

Other financials

Income statement

See full

Operating income-$2.0M+61.2%

Net income-$2.5M+49.6%

EPS (diluted)-$0.05+54.5%

Balance sheet

See full

Cash & equivalents$3.1M+1,132%

Total equity$2.5M-41.5%

Total assets$3.5M—

Cash flow

See full

Operating cash flow-$2.1M-191%

Valuation

See full

Market cap$132.59M-87.6%

Returns & leverage

See full

Return on equity-1,209.8%—

Current ratio3.5×—

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's R&D?: Polaryx Therapeutics, Inc. (PLYX) reported R&D of $679K in Q1 2026.
How has Polaryx Therapeutics, Inc. 's R&D changed year-over-year?: Polaryx Therapeutics, Inc. 's R&D decreased by 85.6% year-over-year, from $4.72M to $679K.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.